Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

IMW 2019 | Amyloidosis: emphasis on early diagnosis

Giampaolo Merlini • 15 Sep 2019
IMW 2019
Amyloidosis Multiple Myeloma Rare Diseases

Giampaolo Merlini, MD University of Pavia, Pavia, Italy highlights the key points regarding amyloidosis treatment, from the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

More from Giampaolo Merlini

The potential of CAR-T therapy for the treatment of amyloidosis 2:18
The potential of CAR-T therapy for the treatment of amyloidosis
Giampaolo Merlini • 10 May 2022
Treatment approaches for amyloidosis patients with advanced cardiac involvement 5:57
Treatment approaches for amyloidosis patients with advanced cardiac involvement
Giampaolo Merlini • 10 May 2022
Novel agents and clinical trials emerging for the treatment of AL amyloidosis 3:23
Novel agents and clinical trials emerging for the treatment of AL amyloidosis
Giampaolo Merlini • 10 May 2022
Advances in AL amyloidosis 3:33
Advances in AL amyloidosis
Giampaolo Merlini • 10 May 2022

Related Videos

The FDA approval of daratumumab for high-risk smoldering myeloma based on the AQUILA trial 10:22
The FDA approval of daratumumab for high-risk smoldering myeloma based on the AQUILA trial
Peter Voorhees • 19 Nov 2025
Promising approaches being explored in high-risk myeloma & trials to look out for 2:11
Promising approaches being explored in high-risk myeloma & trials to look out for
Sham Mailankody • 24 Oct 2025
The value of extensive profiling in single-arm trials for high-risk myeloma 2:39
The value of extensive profiling in single-arm trials for high-risk myeloma
Martin Kaiser • 24 Oct 2025
How is the definition of high-risk myeloma evolving in the era of CAR T-cell therapy? 2:35
How is the definition of high-risk myeloma evolving in the era of CAR T-cell therapy?
Sham Mailankody • 24 Oct 2025
The content of VJHemOnc is intended for healthcare professionals